Literature DB >> 2206785

The effect of food on serum concentrations of metopimazine.

J Herrstedt1, M Jørgensen, H R Angelo.   

Abstract

1. Six healthy volunteers were given single oral doses of the antiemetic metopimazine (MPZ), starting with trial (a) 20 mg preprandially and followed by trial (b) 50 mg preprandially. In trials (c) and (d) the doses were similar to those in trials (a) and (b), but MPZ was given postprandially. To evaluate intra-individual variation in serum concentrations, trial (a) was repeated three times in four of the volunteers (trial (e)). 2. Blood samples were drawn and the serum concentrations of MPZ and its acid metabolite (AMPZ) were measured by h.p.l.c. 3. There was no evidence of dose-dependent kinetics at the dose levels studied. 4. Median AUC values were 22.6, 16.2, 52.4 and 35.2 (trials (a), (b), (c) and (d), ng ml-1 h). Food intake decreased the serum concentrations of MPZ, suggesting that MPZ should be taken preprandially.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2206785      PMCID: PMC1368223          DOI: 10.1111/j.1365-2125.1990.tb03770.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  9 in total

1.  High-performance liquid chromatographic method with fluorescence detection for the simultaneous determination of metopimazine and its acid metabolite in serum.

Authors:  H R Angelo; J Herrstedt; M Jørgensen
Journal:  J Chromatogr       Date:  1989-11-24

Review 2.  Nutritional consequences of cancer chemotherapy and immunotherapy.

Authors:  T Ohnuma; J F Holland
Journal:  Cancer Res       Date:  1977-07       Impact factor: 12.701

3.  Controlled studies of metopimazine for the treatment of nausea and vomiting.

Authors:  C G Moertel; R J Reitemeier
Journal:  J Clin Pharmacol       Date:  1973-07       Impact factor: 3.126

4.  Controlled clinical studies of orally administered antiemetic drugs.

Authors:  C G Moertel; R J Reitemeier
Journal:  Gastroenterology       Date:  1969-09       Impact factor: 22.682

Review 5.  Influence of food on the bioavailability of drugs.

Authors:  A Melander
Journal:  Clin Pharmacokinet       Date:  1978 Sep-Oct       Impact factor: 6.447

6.  Treatment of nausea and vomiting related to anti-cancerous multiple combination chemotherapy: results of two controlled studies.

Authors:  L Israel; C Rodary
Journal:  J Int Med Res       Date:  1978       Impact factor: 1.671

7.  [Clinical evaluation of an antiemetic, metopimazine (Vogalene) in an open and double-blind trial].

Authors:  I Strøyer; S Walbom-Jørgensen; H Sand Hansen
Journal:  Ugeskr Laeger       Date:  1976-07-12

Review 8.  The management of nausea and vomiting in clinical oncology.

Authors:  J B Craig; B L Powell
Journal:  Am J Med Sci       Date:  1987-01       Impact factor: 2.378

9.  Malignancy, weight loss, and the small intestinal mucosa.

Authors:  R E Barry
Journal:  Gut       Date:  1974-07       Impact factor: 23.059

  9 in total
  6 in total

1.  Dose-finding study of oral metopimazine.

Authors:  J Herrstedt; T Sigsgaard; H R Angelo; J P Kampmann; M Hansen
Journal:  Support Care Cancer       Date:  1997-01       Impact factor: 3.603

2.  Interaction of the antiemetic metopimazine and anticancer agents with brain dopamine D2, 5-hydroxytryptamine3, histamine H1, muscarine cholinergic and alpha 1-adrenergic receptors.

Authors:  J Herrstedt; J Hyttel; J Pedersen
Journal:  Cancer Chemother Pharmacol       Date:  1993       Impact factor: 3.333

3.  Randomized, double-blind trial comparing the antiemetic effect of tropisetron plus metopimazine with tropisetron plus placebo in patients receiving multiple cycles of multiple-day cisplatin-based chemotherapy.

Authors:  J Herrstedt; T C Sigsgaard; H A Nielsen; J Handberg; S W Langer; S Ottesen; P Dombernowsky
Journal:  Support Care Cancer       Date:  2006-11-09       Impact factor: 3.359

4.  Pharmacokinetic study of metopimazine by oral route in children.

Authors:  Eric Mallet; Frederic Bounoure; Mohamed Skiba; Elodie Saussereau; Jean-Pierre Goullé; Mireille Castanet
Journal:  Pharmacol Res Perspect       Date:  2015-06-01

5.  Metopimazine is primarily metabolized by a liver amidase in humans.

Authors:  Robert W Busby; Xiaokun Cai; Sihyung Yang; Luis Ramos; Lata Venkatarangan; Helen Shen; Stephen Wax; Abu J M Sadeque; Cyril De Colle
Journal:  Pharmacol Res Perspect       Date:  2022-02

6.  Physicochemical properties of dietary phytochemicals can predict their passive absorption in the human small intestine.

Authors:  Sophie N B Selby-Pham; Rosalind B Miller; Kate Howell; Frank Dunshea; Louise E Bennett
Journal:  Sci Rep       Date:  2017-05-16       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.